Persistent deterioration of short-term memory, progressive confusion and disorientation and frequent agitation are characteristic of Alzheimer’s disease. We have been told that it is largely genetic but that there are some things that can be done to reduce the severity or how early the onset is. We can’t change our genetic makeup but we can change our behavior to help mitigate the effects of this type of dementia. These are all things we can accomplish with a little determination and planning. http://youtu.be/9eMrmVMuAa0
Most of these means of transportation won’t take you a few kilometers from home to work but they’ll do just fine for a stroll in a city park or moving around the office in any case they look unusual and for that alone deserve your attention: so here are the 10 craziest means of transportation. №1 Double- round skate Unlike a conventional skates the double round model allows you to freely manage your feet turn and spin at the heart of the skateboarder two wheels with a diameter of 25 centimeters and a comfortable platform for the feet. No 2: Hoverboard Levitating an inch above the ground the hendo borders for disc straight motors that create a magnetic field repelling the board from the ground or rather from a non ferromagnetic material over which it harbors. No 3: One wheel electric Skateboard The one-wheel skate is a self-balancing unicycle electro mechanical skateboard in simple terms it’s a new toy for adults, boys and girls it reaches speeds of about 19 km/h. No 4: Aeyo Segue started a flood of developments in the field of devices for personal mobility and some designs are quite crazy. Aeyo is a cross between a scooter a bike and a pair of roller skates which falls in the middle of the scale. No 5: Half-Bike Riding a half bike is a combination of running and cycling because you’re in a standing position and so the bike responds better to your body’s movements and turns more agility more fun and the surprise looks of passes by.No 6: Air Bike Aero-X
https://www.youtube.com/watch?v=izM7RPiN7L4
Today Barclaycard US, the payments business of Barclays in the United States, announced the launch of the #IHAVEARRIVED Travel Community contest, hosted by Barclaycard Arrival™ MasterCard®. Travel enthusiasts and Barclaycard Arrival cardmembers are invited to join the Barclaycard Travel Community to share their #IHAVEARRIVED travel moment. Barclaycard Arrival cardmembers who enter, have the opportunity to win an exclusive grand prize trip for two to the 58th Annual GRAMMY Awards® in February 2016. Community members who are not Barclaycard Arrival cardmembers have an opportunity to choose between two grand prize options: a West Coast VIP trip for two to Napa Valley, California or an East Coast VIP trip for two to New York City.
“Since launching in 2013, Barclaycard Arrival continues to be recognized by industry experts as the go-to travel card,” said Maurice Ragland, vice president of branded cards. “We make it easy for cardmembers to have once-in-a-lifetime adventures by offering the industry’s best travel rewards program. What better way to showcase these moments than through the #IHAVEARRIVED campaign.”
Travel enthusiasts across the country are encouraged to share memorable travel stories from October 28 through November 22 in the Barclaycard Travel Community. Entries must include a short description and photo of the travel experience. Entries will be judged on originality, creativity, writing and photography.
To view the multimedia release go to:
http://www.multivu.com/players/English/7671251-barclaycard-ihavearrived-launch/
The Yankee Candle Company, Inc., the world’s largest manufacturer of premium scented candles, today announced the launch of two new fragrances and the return of three favorites in its popular limited edition Man Candles collection. Just in time for Father’s Day, Camouflage and On Tap™ join last year’s introduction MMM, Bacon!™ and original Man Candles Man Town™ and Riding Mower™. The Man Candles collection, which was an instant hit when it debuted in 2012, was created uniquely for men to enjoy in their “man town,” wherever that may be in the house. These limited edition fragrances are available now at Yankee Candle’s over 500 retail stores, at www.yankeecandle.com and select specialty retailers and gift shops. Yankee Candle is launching a series of social media contests offering consumers the chance to win samples of the Man Candles III collection!
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7221651-yankee-candle-heads-outdoors-new-man-candles-fragrances
There is only one choice when it come to nutrition that slows down kidney disease and helps joint problems at the same time - The Hill's Science Diet K/D + Mobility.
Learn more here: https://tier1petproducts.com/best-dog-food-for-kidney-disease/
Chronic kidney disease (CKD) is a condition often associated with advanced age. According to recent data 1 out of 10 dogs will develop CKD in his lifetime.
It is also common for senior dogs to develop other age-related conditions such as reduced mobility or cognitive dysfunction which can significantly impact the quality of life of both the pet and the pet parent.
Nutrition can play a key role in managing these age-related conditions. That is why Hill’s nutritionists and veterinarians developed new Prescription Diet K/D + Mobility for dogs.
Peeling an orange picked fresh off a backyard tree. Enjoying a refreshing lemonade on a hot summer’s day. Sharing a juicy mandarin with your kids after school. These are some of America’s favorite moments and they’re all at risk because California citrus is facing a major threat from a tiny insect and the devastating disease it can spread.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7452951-bayer-cropscience-california-citrus/
Bindu is a small settlement or a village situated at an altitude of nearly 700 meters on the India Bhutan border. These are lesser known hill stations and offer beautiful landscape and peace It is known for cardamom plantation and the journey through Chapramari Sanctuary is a pleasant experience.
Visit: http://www.SanjayCPatel.com ~ God Is Real - The Stunning NEW Convergence of Science and Spirituality. Over 100 New Proofs of God from the Bible, Ancient Yoga, and Modern Science!
Finally, after centuries of search, the holy grail of all proofs demonstrating God is real has arrived. Whether you are interested in proof of God for yourself or a skeptical teenager, these new discoveries proving God is real will forever change the way you view the ancient scriptures of Israel and their metaphorical descriptions of our world. It turns out that the ancient metaphors were not ad hoc. They had a deeper meaning and were meticulously modeled.
Hugely important, some of them have been published in three international science journals -- the gold standard of scientific research -- and hailed by many as one of the most important discoveries of this century.
By Sanjay C. Patel Visit http://www.SanjayCPatel.com
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
E FUN introduces the Nextbook Flexx line of 2-in-1 tablets with Windows 8.1. The new 11.6” Flexx 11 and its smaller sibling, the 10.1” Flexx 10, deliver a great value with the best features of a tablet and laptop, including a detachable POGO keyboard and touch screen. Designed for the budget-conscious consumer, these Intel-powered tablets are offered at select* Walmart stores and Walmart.com for $227 (Flexx 11) and $178 (Flexx 10). Owners of the Nextbook Flexx tablets can upgrade to Windows 10 for free** starting July 29.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7515651-e-fun-nextbook-flexx-2-in-1/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
